Sirolimus and thrombotic microangiopathy after allogeneic stem cell transplantation.

被引：3
|
作者：
Henry, NL
Li, SL
Kim, HT
Magee, C
Alyea, E
Ho, V
Lee, SJ
Soiffer, R
Antin, JH
Cutler, C
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.1834.1834
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1834
引用
收藏
页码：508A / 508A
页数：1
相关论文
共 50 条
  • [31] Sirolimus-related Systemic Thrombotic Microangiopathy after Renal Transplantation
    Negrini, Simone
    Durrbach, Antoine
    Becquemont, Laurent
    [J]. THERAPIE, 2014, 69 (02): : 175 - 177
  • [32] Thrombotic Microangiopathy Associated with Sirolimus Level after Allogeneic Hematopoietic Cell Transplantation with Tacrolimus/Sirolimus-Based Graft-versus-Host Disease Prophylaxis
    Shayani, Sepideh
    Palmer, Joycelynne
    Stiller, Tracey
    Liu, Xueli
    Thomas, Sandra H.
    Khuu, Tam
    Parker, Pablo M.
    Khaled, Samer K.
    Forman, Stephen J.
    Nakamura, Ryotaro
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : 298 - 304
  • [33] Causes of death by necropsy after allogeneic stem cell transplantation.
    Quiñones, MDP
    Palomino, EA
    Yabar, A
    Carrasco-Yalan, AA
    Castillo, J
    Navarro, JR
    [J]. BLOOD, 2003, 102 (11) : 461B - 462B
  • [34] Costs of complications after allogeneic myeloablative stem cell transplantation.
    Saito, Akiko M.
    Cutler, Corey
    Zahrieh, David
    Ho, Vincent T.
    Alyea, Edwin P.
    Soiffer, Robert J.
    Antin, Joseph H.
    Lee, Stephanie J.
    [J]. BLOOD, 2006, 108 (11) : 844A - 844A
  • [35] Identification and prognosis impact of intestinal thrombotic microangiopathy after allogeneic stem cell transplant
    Labrador, J.
    Lopez-Corral, L.
    Alonso, S.
    Lopez-Godino, O.
    Blanco, O.
    Velasco, A.
    Perez, E.
    Cabrero, M.
    Sanchez-Guijo, F.
    Vazquez, L.
    Gonzalez-Porras, J. -R.
    Caballero, D.
    [J]. BONE MARROW TRANSPLANTATION, 2016, 51 : S80 - S81
  • [36] Safety of voriconazole after autologous and allogeneic stem cell transplantation.
    Restrepo, MH
    Langston, AA
    Shayani, S
    Waller, EK
    Lonial, S
    [J]. BLOOD, 2003, 102 (11) : 454B - 454B
  • [37] RENAL AND NEUROLOGICAL RESPONSE WITH ECULIZUMAB IN A PATIENT WITH TRANSPLANT ASSOCIATED THROMBOTIC MICROANGIOPATHY AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Sevindik, O. G.
    Alacacioglu, I.
    Katgi, A.
    Solmaz, S. Medeni
    Acar, C.
    Piskin, O.
    Ozcan, M. Ali
    Demirkan, F.
    Undar, B.
    Ozsan, G. Hayri
    [J]. BONE MARROW TRANSPLANTATION, 2014, 49 : S486 - S487
  • [38] Comparison of various diagnostic criteria of thrombotic microangiopathy after stem cell transplantation
    Horvath, O.
    Kallay, K.
    Csuka, D.
    Kassa, C.
    Strehn, A.
    Csordas, K.
    Prohaszka, Z.
    Krivan, G.
    [J]. BONE MARROW TRANSPLANTATION, 2017, 52 : S279 - S280
  • [39] Successful treatment of thrombotic microangiopathy after haematopoietic stem cell transplantation with rituximab
    Au, Wing-Yan
    Ma, Edmond S.
    Lee, Tsz-Leung
    Ha, Shau-Yin
    Fung, Alvin T.
    Lie, Albert K. W.
    Kwong, Yok-Lam
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2007, 137 (05) : 475 - 478
  • [40] Risk factor analysis for thrombotic microangiopathy after reduced-intensity or myeloablative allogeneic hematopoietic stem cell transplantation
    Nakamae, Hirohisa
    Yamane, Takahisa
    Hasegawa, Taro
    Nakamae, Mika
    Terada, Yoshiki
    Hagihara, Kiyoyuki
    Ohta, Kensuke
    Hino, Masayuki
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2006, 81 (07) : 525 - 531
12345